This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Regents of the University of Minnesota. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Walker Lahr: Innovator in Gene Editing Technology
Introduction
Walker Lahr is a prominent inventor based in Minneapolis, MN. He has made significant contributions to the field of gene editing, particularly through his innovative work at the University of Minnesota. His research focuses on advancing techniques that can potentially revolutionize immunotherapy.
Latest Patents
Walker Lahr holds a patent for "Lymphohematopoietic engineering using CAS9 base editors." This patent outlines methods and systems for targeted gene disruption and targeted gene knock-in in mammalian cells. The technology utilizes base editors and guide RNAs designed to target splice acceptor-splice donor sites. Additionally, the patent describes genetically engineered cells with targeted disruptions in immunotherapy-related genes, which include a CAR/TCR for therapeutic applications. He has 1 patent to his name.
Career Highlights
Lahr's career at the University of Minnesota has been marked by his dedication to advancing gene editing technologies. His work has the potential to impact various therapeutic applications, particularly in the field of immunotherapy.
Collaborations
Walker collaborates with notable colleagues, including Branden Moriarity and Beau R Webber. Their combined expertise enhances the research and development of innovative gene editing solutions.
Conclusion
Walker Lahr is a key figure in the field of gene editing, with a focus on developing advanced techniques for immunotherapy. His contributions through his patent and collaborations position him as an influential inventor in this rapidly evolving area of research.